Related Experiment Video
Updated: Jun 7, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Update on St. John's Wort
1University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, 15213, USA. HowlandRH@upmc.edu
St. John's wort (SJW) is an effective herbal depression treatment, comparable to conventional drugs but with fewer side effects. However, potential drug interactions require careful consideration.
Area of Science:
- Integrative Medicine
- Pharmacology
- Psychiatry
Background:
- Herbal remedies for depression are popular due to accessibility and perceived safety.
- St. John's wort (SJW) is a widely recognized herbal therapy for depression.
Purpose of the Study:
- To evaluate the efficacy and safety of St. John's wort (SJW) for major depression.
- To compare SJW with placebo and conventional antidepressant drugs.
Main Methods:
- Meta-analysis of randomized controlled trials (RCTs) investigating SJW for depression.
- Analysis of comparative effectiveness and side effect profiles.
Main Results:
- SJW demonstrated superiority over placebo in treating major depression.
- SJW showed comparable efficacy to conventional antidepressants.
- A significant degree of heterogeneity exists in placebo-controlled studies, with German-speaking countries reporting more favorable outcomes.
- SJW is generally well-tolerated, with a potential for fewer side effects than some antidepressants.
- Limited data suggests SJW may be safe during pregnancy and breastfeeding.
- SJW is associated with significant drug-drug interactions.
Conclusions:
- St. John's wort is an effective treatment option for major depression.
- While generally safe and effective, SJW's use requires caution due to potential drug interactions.
- Further research is needed to clarify heterogeneity in study findings and confirm safety in specific populations.
Related Concept Videos
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Therapeutic Drug Monitoring: Affecting Factors
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
FDA Approved Drugs: Changes to Approved Drugs
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence